[PDF][PDF] CXCL12 rs1801157 polymorphism is associated with risk and poor prognosis of non-Hodgkins Lymphoma

AA RS, A Rabea, OY Abd El Dayem - Age - secioj.journals.ekb.eg
Background: CXCL12 and its receptor CXCR4 belong to the CXC family of chemokines that
regulate the migration of immune cells during their development and in inflammatory …

CXCL12 rs18011157 polymorphısm in patients wıth non-Hodgkin's lymphoma: Is it associated with poor outcome?

GE Pamuk, H Tozkır, MS Uyanık… - Journal of Cancer …, 2018 - journals.lww.com
Objective: We studied CXCL12-related rs18011157 polymorphism in non-Hodgkin
lymphoma (NHL) patients. We also determined the effect of this polymorphism on clinical …

CXCR5 polymorphisms in non-Hodgkin lymphoma risk and prognosis

B Charbonneau, AH Wang, MJ Maurer… - Cancer Immunology …, 2013 - Springer
Abstract CXCR5 [chemokine (CXC motif) receptor 5; also known as Burkitt lymphoma
receptor 1 (BCR1)] is expressed on mature B-cells, subsets of CD4+ and CD8+ T-cells, and …

CXC Chemokine Receptor Type 5 Gene Polymorphisms in a Cohort of Egyptian Patients with Diffuse Large B-Cell Lymphoma

MM Makhlouf, ER Radwan, OM Khorshed, LM Fathi… - Pathobiology, 2021 - karger.com
Background: The chemokine receptor CXCR5 is selectively expressed on B cells; it is
involved in lymphocyte homing and the development of normal lymphoid tissue. Its principle …

CXC chemokine receptor type 5 gene polymorphisms are associated with non-Hodgkin lymphoma

H Song, D Tong, Z Cha, J Bai - Molecular biology reports, 2012 - Springer
The CXC chemokine receptor type 5 (CXCR5) is one of the principal regulators for targeting
T cells, B cells and dendritic cells into secondary lymphoid organs. Polymorphism studies of …

CXCL12 rs1801157 polymorphism in patients with breast cancer, hodgkin's lymphoma, and non‐hodgkin's lymphoma

KB de Oliveira, JMM Oda, JC Voltarelli… - Journal of clinical …, 2009 - Wiley Online Library
Chemokines and their receptors regulate the trafficking of immune cells during their
development, inflammation, and tissue repair. The single‐nucleotide polymorphism (SNP) …

The CXCL12 G801A polymorphism is associated with cancer risk: a meta-analysis

K Zhu, B Jiang, R Hu, Y Yang, M Miao, Y Li, Z Liu - PloS one, 2014 - journals.plos.org
Background CXCL12 is a small chemotactic cytokine belonging to the CXC chemokine
family expressed in various organs. It contributes to the migration, invasion and …

CXCL12 rs1801157 polymorphism and expression in peripheral blood from breast cancer patients

KB de Oliveira, RL Guembarovski, JMM Oda… - Cytokine, 2011 - Elsevier
The role of chemokines has been extensively analyzed both in cancer risk and tumor
progression. Among different cytokines, CXCR4 and its ligand CXCL12 have been recently …

Expression and gene polymorphisms of the chemokine CXCL5 in colorectal cancer patients

J Dimberg, O Dienus, S Löfgren… - International …, 2007 - spandidos-publications.com
Several studies indicate that chemokines play important roles in colorectal mucosal
immunity by recruiting leukocytes into and out of the lamina propria adjacent to the …

Polymorphism and circulating levels of the chemokine CXCL12 in colorectal cancer patients

J Dimberg, A Hugander… - … journal of molecular …, 2007 - spandidos-publications.com
The chemokine CXCL12, also known as stromal cell-derived factor-1 (SDF-1), is a small
protein that regulates leukocyte trafficking and is variably expressed in a number of normal …